Resveratrol induces MMP-9 and cell migration via the p38 kinase and PI-3K pathways in HT1080 human fibrosarcoma cells

Oncology Reports

Volumn 29, Issue 2, 2013, Pages 826-834

  Gweon, Eun Jeong ^a   Kim, Song Ja ^a  

^a Kongju National University   (South Korea)

Author keywords

HT1080; Matrix metalloproteinase 9; Migration; P38 kinase; Phosphatidylinositol 3 kinase; Resveratrol

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; GELATINASE B; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; RESVERATROL;

ARTICLE; CELL ASSAY; CELL MIGRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENTIATION; DRUG TARGETING; ENZYME INHIBITION; FIBROSARCOMA; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; WESTERN BLOTTING; WOUND HEALING; ZYMOGRAPHY;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROSARCOMA; HUMANS; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 9; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; STILBENES;

EID: 84872770831     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.2151     Document Type: Article

References (48)

1. Brisdelli F, D'Andrea G and Bozzi A: Resveratrol: a natural polyphenol with multiple chemopreventive properties. Curr Drug Metab 10: 530-546, 2009.
2. Cao Y, Cao R and Brakenhielm E: Antiangiogenic mechanisms of diet-derived polyphenols. J Nutr Biochem 13: 380-390, 2002. (Pubitemid 34733007)
3. Brakenhielm E, Cao R and Cao Y: Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes. FASEB J 15: 1798-1800, 2001.
4. 2-induced adenocarcinoma gastric cell proliferation via inactivation of MEK1/2-ERK1/2-c-jun signalling axis. Biochem Pharmacol 77: 337-347, 2009.
5. Kozuki Y, Miura Y and Yagasaki K: Resveratrol suppresses hepatoma cell invasion independently of its antiproliferative action. Cancer Lett 167: 151-156, 2001. (Pubitemid 32706677)
6. Woo JH, Lim JH, Kim YH, et al: Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting JNK and PKC delta signal transduction. Oncogene 23: 1845-1853, 2004. (Pubitemid 38445410)
7. Sun C, Hu Y, Liu X, et al: Resveratrol downregulates the constitutional activation of nuclear factor-kappaB in multiple myeloma cells, leading to suppression of proliferation and invasion, arrest of cell cycle, and induction of apoptosis. Cancer Genet Cytogenet 165: 9-19, 2006. (Pubitemid 43254647)
8. Klinge CM, Blankenship KA, Risinger KE, et al: Resveratrol and estradiol rapidly activate MAPK signaling through estrogen receptors alpha and beta in endothelial cells. J Biol Chem 280: 7460-7468, 2005. (Pubitemid 40349637)
9. Aziz MH, Kumar R and Ahmad N: Cancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms (Review). Int J Oncol 23: 17-28, 2003.
10. Tang FY, Chiang EP and Sun YC: Resveratrol inhibits heregulin-beta1- mediated matrix metalloproteinase-9 expression and cell invasion in human breast cancer cells. J Nutr Biochem 19: 287-294, 2008.
11. Yilmaz M, Christofori G and Lehembre F: Distinct mechanisms of tumor invasion and metastasis. Trends Mol Med 13: 535-541, 2007. (Pubitemid 350123764)
12. Woessner JF Jr: Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5: 2145-2154, 1991. (Pubitemid 21905847)
13. Hidalgo M and Eckhardt SG: Development of matrix metalloproteinase inhibitors in cancer therapy. J Natl Cancer Inst 93: 178-193, 2001. (Pubitemid 32166488)
14. Roach DM, Fitridge RA, Laws PE, Millard SH, Varelias A and Cowled PA: Up-regulation of MMP-2 and MMP-9 leads to degradation of type IV collagen during skeletal muscle reperfusion injury; protection by the MMP inhibitor, doxycycline. Eur J Vasc Endovasc Surg 23: 260-269, 2002. (Pubitemid 41079468)
15. Bachmeier BE, Iancu CM, Jochum M and Nerlich AG: Matrix metalloproteinases in cancer: comparison of known and novel aspects of their inhibition as a therapeutic approach. Expert Rev Anticancer Ther 5: 149-163, 2005. (Pubitemid 40287445)
16. Lee SO, Jeong YJ, Im HG, Kim CH, Chang YC and Lee IS: Silibinin suppresses PMA-induced MMP-9 expression by blocking the AP-1 activation via MAPK signaling pathways in MCF-7 human breast carcinoma cells. Biochem Biophys Res Commun 354: 165-171, 2007. (Pubitemid 46123215)
17. Dhillon AS, Hagan S, Rath O and Kolch W: MAP kinase signalling pathways in cancer. Oncogene 26: 3279-3290, 2007. (Pubitemid 46763021)
18. Bradham C and McClay DR: p38 MAPK in development and cancer. Cell Cycle 5: 824-828, 2006. (Pubitemid 44145574)
19. Lee SJ, Kim WJ and Moon SK: Role of the p38 MAPK signaling pathway in mediating interleukin-28A-induced migration of UMUC-3 cells. Int J Mol Med 30: 945-952, 2012.
20. Zhang B, Wang X, Cai F, Chen W, Loesch U, Bitzer J and Zhong XY: Effects of salinomycin on human ovarian cancer cell line OV2008 are associated with modulating p38 MAPK. Tumour Biol: July 7, 2012 (Epub ahead of print).
21. Foster FM, Traer CJ, Abraham SM and Fry MJ: The phosphoinositide (PI) 3-kinase family. J Cell Sci 116: 3037-3040, 2003. (Pubitemid 37038952)
22. Cotrim CZ, Fabris V, Doria ML, et al: Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells. Oncogene: July 2, 2012 (Epub ahead of print).
23. Dineva IK, Zaharieva MM, Konstantinov SM, Eibl H and Berger MR: Erufosine suppresses breast cancer in vitro and in vivo for its activity on PI3K, c-Raf and Akt proteins. J Cancer Res Clin Oncol: June 30, 2012 (Epub ahead of print).
24. Park SY, Kim YH, Kim YH and Lee SJ: Aromatic-turmerone attenuates invasion and expression of MMP-9 and COX-2 through inhibition of NF-κB activation in TPA-induced breast cancer cells. J Cell Biochem: June 27, 2012 (Epub a head of print).
25. Nam KS and Shon YH: Suppression of metastasis of human breast cancer cells by chitosan oligosaccharides. J Microbiol Biotechnol 19: 629-633, 2009.
26. Lu N, Ling Y, Gao Y, et al: Endostar suppresses invasion through downregulating the expression of matrix metalloproteinase-2/9 in MDA-MB-435 human breast cancer cells. Exp Biol Med (Maywood) 233: 1013-1020, 2008.
27. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E and Seiki M: A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370: 61-65, 1994. (Pubitemid 24216953)
28. Khokha R: Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the over-expression of the tissue inhibitor of the metalloproteinases-1. J Natl Cancer Inst 86: 299-304, 1994. (Pubitemid 24057409)
29. Rosenblum G, Meroueh SO, Kleifeld O, et al: Structural basis for potent slow binding inhibition of human matrix metalloproteinase-2 (MMP-2). J Biol Chem 278: 27009-27015, 2003. (Pubitemid 36880803)
30. Kim ES, Sohn YW and Moon A: TGF-beta-induced transcriptional activation of MMP-2 is mediated by activating transcription factor (ATF)2 in human breast epithelial cells. Cancer Lett 252: 147-156, 2007. (Pubitemid 46738609)
31. Cohen M, Meisser A, Haenggeli L and Bischof P: Involvement of MAPK pathway in TNF-alpha-induced MMP-9 expression in human trophoblastic cells. Mol Hum Reprod 12: 225-232, 2006. (Pubitemid 43779073)
32. Kajanne R, Miettinen P, Mehlem A, et al: EGF-R regulates MMP function in fibroblasts through MAPK and AP-1 pathways. J Cell Physiol 212: 489-497, 2007. (Pubitemid 47025639)
33. Westermarck J, Holmström T, Ahonen M, et al: Enhancement of fibroblast collagenase-1 (MMP-1) gene expression by tumor promoter okadaic acid is mediated by stress-activated protein kinases Jun N-terminal kinase and p38. Matrix Biol 17: 547-557, 1998. (Pubitemid 29017223)
34. Cho HJ, Kang JH, Kwak JY, et al: Ascofuranone suppresses PMA-mediated matrix metalloproteinase-9 gene activation through the Ras/Raf/MEK/ERK- and Ap1-dependent mechanisms. Carcinogenesis 28: 1104-1110, 2007. (Pubitemid 47072197)
35. Hong IK, Kim YM, Jeoung DI, Kim KC and Lee H: Tetraspanin CD9 induces MMP-2 expression by activating p38 MAPK, JNK and c-Jun pathways in human melanoma cells. Exp Mol Med 37: 230-239, 2005. (Pubitemid 40992739)
36. Wang L, Ling Y, Chen Y, et al: Flavonoid baicalein suppresses adhesion, migration and invasion of MDA-MB-231 human breast cancer cells. Cancer Lett 297: 42-48, 2010.
37. Zhang C, Li Y, Qian Z J, Lee SH, Li YX and Kim SK: Dieckol from Ecklonia cava regulates invasion of human fibrosarcoma cells and modulates MMP-2 and MMP-9 expression via NF-κB path way. Evid Based Complement Alternat Med 2011: 140462, 2011.
38. Chen P, Lu N, Ling Y, et al: Inhibitory effects of wogonin on the invasion of human breast carcinoma cells by downregulating the expression and activity of matrix metalloproteinase-9. Toxicology 282: 122-128, 2011.
39. Tang FY, Su YC, Chen NC, Hsieh HS and Chen KS: Resveratrol inhibits migration and invasion of human breast-cancer cells. Mol Nutr Food Res 52: 683-691, 2008.
40. Johnson MK and Loo G: Effects of epigallocatechin gallate and quercetin on oxidative damage to cellular DNA. Mutat Res 459: 211-218, 2000. (Pubitemid 30254308)
41. Liu PL, Tsai JR, Charles AL, et al: Resveratrol inhibits human lung adenocarcinoma cell metastasis by suppressing heme oxygenase 1-mediated nuclear factor-kappaB pathway and subsequently downregulating expression of matrix metalloproteinases. Mol Nutr Food Res 54 (Suppl 2): S196-S204, 2010.
42. Lee SJ and Kim MM: Resveratrol with antioxidant activity inhibits matrix metalloproteinase via modulation of SIRT1 in human fibrosarcoma cells. Life Sci 88: 465-472, 2011.
43. Park JS, Kim KM, Kim MH, et al: Resveratrol inhibits tumor cell adhesion to endothelial cells by blocking ICAM-1 expression. Anticancer Res 29: 355-362, 2009.
44. Lee MF, Pan MH, Chiou YS, Cheng AC and Huang H: Resveratrol modulates MED28 (Magicin/EG-1) expression and inhibits epidermal growth factor (EGF)-induced migration in MDA-MB-231 human breast cancer cells. J Agric Food Chem 59: 11853-11861, 2011.
45. Yar AS, Menevse S and Alp E: The effects of resveratrol on cyclooxygenase-1 and -2, nuclear factor kappa beta, matrix metalloproteinase-9, and sirtuin 1 mRNA expression in hearts of streptozotocin-induced diabetic rats. Genet Mol Res 10: 2962-2975, 2011.
46. Weng CJ, Wu CF, Huang HW, Wu CH, Ho CT and Yen GC: Evaluation of anti-invasion effect of resveratrol and related methoxy analogues on human hepatocarcinoma cells. J Agric Food Chem 58: 2886-2894, 2010.
47. Liao PC, Ng LT, Lin LT, Richardson CD, Wang GH and Lin CC: Resveratrol arrests cell cycle and induces apoptosis in human hepatocellular carcinoma Huh-7 cells. J Med Food 13: 1415-1423, 2010.
48. Wang Z, Li W, Meng X and Jia B: Resveratrol induces gastric cancer cell apoptosis via reactive oxygen species, but independent of sirtuin1. Clin Exp Pharmacol Physiol 39: 227-232, 2012.